177 related articles for article (PubMed ID: 11489005)
1. Intraperitoneal hyperthermic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal disseminated ovarian cancer.
Hager ED; Dziambor H; Höhmann D; Mühe N; Strama H
Int J Gynecol Cancer; 2001; 11 Suppl 1():57-63. PubMed ID: 11489005
[TBL] [Abstract][Full Text] [Related]
2. Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery.
Bae JH; Lee JM; Ryu KS; Lee YS; Park YG; Hur SY; Ahn WS; Namkoong SE
Gynecol Oncol; 2007 Jul; 106(1):193-200. PubMed ID: 17466362
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinoma.
Lentz SS; Miller BE; Kucera GL; Levine EA
Gynecol Oncol; 2007 Jul; 106(1):207-10. PubMed ID: 17498782
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma.
Helm CW; Randall-Whitis L; Martin RS; Metzinger DS; Gordinier ME; Parker LP; Edwards RP
Gynecol Oncol; 2007 Apr; 105(1):90-6. PubMed ID: 17173957
[TBL] [Abstract][Full Text] [Related]
5. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer.
Ryu KS; Kim JH; Ko HS; Kim JW; Ahn WS; Park YG; Kim SJ; Lee JM
Gynecol Oncol; 2004 Aug; 94(2):325-32. PubMed ID: 15297169
[TBL] [Abstract][Full Text] [Related]
6. [Intraperitoneal hyperthermic perfusion chemotherapy in recurrent ovarian cancer].
Wydra D; Emerich J
Ginekol Pol; 2002 Nov; 73(11):1044-7. PubMed ID: 12722397
[TBL] [Abstract][Full Text] [Related]
7. [Intraperitoneal hyperthermic chemotherapy (IPHC), a promising treatment of peritoneal carcinomatosis].
Detroz B; Elias D; Damia E; Debaene B; Rougier P; Lasser P
Bull Cancer; 1994 Mar; 81(3):182-93. PubMed ID: 7894126
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal hyperthermic chemotherapy in ovarian cancer.
Gori J; Castaño R; Toziano M; Häbich D; Staringer J; De Quirós DG; Felci N
Int J Gynecol Cancer; 2005; 15(2):233-9. PubMed ID: 15823105
[TBL] [Abstract][Full Text] [Related]
9. Cytologic assessment before and after intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.
Loggie BW; Fleming RA; Geisinger KR
Acta Cytol; 1996; 40(6):1154-8. PubMed ID: 8960022
[TBL] [Abstract][Full Text] [Related]
10. Cytoreduction and intraperitoneal heated chemotherapy for the treatment of endometrial carcinoma recurrent within the peritoneal cavity.
Helm CW; Toler CR; Martin RS; Gordinier ME; Parker LP; Metzinger DS; Edwards RP
Int J Gynecol Cancer; 2007; 17(1):204-9. PubMed ID: 17291254
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of neoadjuvant chemotherapy combined with intraperitoneal hyperthermic chemotherapy in advanced ovarian cancer.
Xu Z; Ge X; Zhang T; Shi Y; Sun M
J BUON; 2020; 25(2):772-778. PubMed ID: 32521866
[TBL] [Abstract][Full Text] [Related]
12. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy.
Stewart JH; Shen P; Russell GB; Bradley RF; Hundley JC; Loggie BL; Geisinger KR; Levine EA
Ann Surg Oncol; 2006 May; 13(5):624-34. PubMed ID: 16538401
[TBL] [Abstract][Full Text] [Related]
13. A systematic overview of chemotherapy effects in ovarian cancer.
Högberg T; Glimelius B; Nygren P;
Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
[TBL] [Abstract][Full Text] [Related]
14. A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers.
Stewart JH; Shen P; Russell G; Fenstermaker J; McWilliams L; Coldrun FM; Levine KE; Jones BT; Levine EA
Ann Surg Oncol; 2008 Aug; 15(8):2137-45. PubMed ID: 18493824
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal hyperthermic chemotherapy: an evolving paradigm for the treatment of peritoneal surface malignancies.
Stewart JH; Shen P; Levine EA
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1809-18. PubMed ID: 18983241
[TBL] [Abstract][Full Text] [Related]
16. Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.
Massari R; Barone M; Basilico R; Carella C; Colasante A; De Tursi M; Filippone A; Guetti L; Mani A
Minerva Chir; 2014 Feb; 69(1):17-26. PubMed ID: 24675243
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in the treatment of peritoneal carcinomatosis.
Gammon DC; Dutton T; Piperdi B; Zybert J; Wolfe SH; Nguyen E; Sbat D; Pillarisetty VG; Sullivan M; Whalen GF
Am J Health Syst Pharm; 2009 Jul; 66(13):1186-90. PubMed ID: 19535657
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of type-B ultrasound-guided intraperitoneal hyperthermic chemoperfusion combined with systemic chemotherapy in advanced gastric cancer patients with malignant ascites.
Lu C; Li L; Luo Z; Cui Y; Fu P; Zhou J; Ma N; Zhou Y
Neoplasma; 2016; 63(2):299-303. PubMed ID: 26774152
[TBL] [Abstract][Full Text] [Related]
19. Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.
Gray HJ; Shah CA; Swensen RE; Tamimi HK; Goff BA
Gynecol Oncol; 2010 Mar; 116(3):340-4. PubMed ID: 19922987
[TBL] [Abstract][Full Text] [Related]
20. Positive experience of intraperitoneal chemotherapy followed by intravenous chemotherapy in heavily pretreated patients with suboptimal residual ovarian cancer and primary peritoneal cancer.
Nicoletto MO; Dalla Palma M; Donach ME; Gusella M; Cappetta A; Shams M; Marchet A; Nardin M; Pintacuda G; Di Maggio A; Marchesi M; Carli P; Fiduccia P; Artioli G; Nitti D
Tumori; 2010; 96(6):918-25. PubMed ID: 21388052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
